[1] 胡学芹,王畅,田园.腹膜透析相关性腹膜炎临床特点和病原学及其预后[J].中华医院感染学杂志,2019,29(14):2125-2129.
[2] HAMADA S,TAKATA T,KITAURA T,et al. Peritoneal dialysis-as-sociated peritonitis caused by Mycobacteroidesmassiliense:the first case and review of the literature[J]. BMC Nephrol,2021 ,22(1):90.
[3] SAHLAWI M A,WILSON G,STALLARD B,et al. Peritoneal dialy-sis-associated peritonitis outcomes reported in trials and observa-tional studies:a systematic review [J]. Perit Dial Int,2020,40(2):132-140.
[4] XU L C,ZHOU F F,LI M,et al. Predictive value of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on patient survival with peritoneal dialysis[J]. Clin Lab,2021,67(9):154-156.
[5] CHEN T,YANG M. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients[J]. Int Immunopharmacol,2020,2(1):102-104.
[6] ASIK Z. The role of the NLR and PLR in urinary tract infection[J]. Clin Lab,2021,67(10):152-154.
[7] MANDALIYA H,JONES M,OLDMEADOE C,et al. Prognostic biomarkers in stageⅣ non-small cell lung cancer(NSCLC):neu-trophil to lymphocyte ratio(NLR),lymphocyte to monocyte ratio (LMR),platelet to lymphocyte ratio(PLR)and advanced lung can-cer inflammation index(ALI)[J]. Transl Lung Cancer Res,2019,8(6):886-894.
[8] 王萍,俞雨生. 2016 ISPD关于腹膜透析相关腹膜炎防治指南的解读[J].肾 脏病与透析肾 移植杂志,2017,26(3):282-286.
[9] 马东红,吕玉敏,刘云,等.腹膜透析相关性腹膜炎临床特点与危险因素分析[J].中国血液净化,2018,17(2):73-77.
[10]王璐瑶,窦艳娜,肖静,等.早发性腹膜透析相关性腹膜炎的危险因素研究[J].中国全科医学,2017,20(4):454-458.
[11] AL ASHLAWI M,BARGMAN J M,PERL J. Peritoneal dialysis-as-sociated peritonitis:suggestions for management and mistakes to avoid[J]. Kidney Med,2020,2(4):467-475.
[12] SZETO C C,LI P K. Peritoneal dialysis-associated peritonitis [J]. Clin J Am Soc Nephrol,2019,14(7):1100-1105.
[13] HE P,HE L J,HUANG C,et al. Neutrophil-to-lymphocyte ratio and treatment failure in peritoneal dialysis-associated peritonitis [J]. Front Med(Lausanne),2021 ,8(7):699502.
[14] LIU S,YANG M,ZHAO Q,et al. Platelet-to-lymphocyte ratio is as-sociated with the mortality in peritoneal dialysis patients[J]. Iran J Kidney Dis,2021,15(3):206-212.
[15] DJORDJEVIC D,RONDOVIC G,SURBATOVIC M,et al. Neutrophil-to-lymphocyte ratio,monocyte-to-lymphocyte ratio,platelet-to-lymphocyte ratio,and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients:which ratio to choose to predict outcome and nature of bacteremia? [J]. Mediators Inflamm,2018,7(2):1546-1548.
[16]方 味味,刘桂凌,李庆根,等. NLR和PLR在腹膜透析相关性感染中的诊断价值探讨[J].临床肾 脏病杂志,2020,15(3):12-18.
[17]吴岳春,黄庆龙,杨明榴,等. NLR与MLR对 腹膜透析患者腹腔感染的诊断及预后评估价值[J].中华医院感染学杂志,2021,31(6):852-856.
[18]林蓉宇,陈文.外周血NLR,PLR,CRP检测在老年腹膜透析相关性感染诊断中的价值分析[J].川北医学院学报,2022,37(6):734-737.
[1]林美华,郭小云,李洪钧,等.腹膜透析患者血清NGAL水平与微炎症状态的关系[J].天津医科大学学报,2013,19(05):396.
[2]孙 鹏,夏 天.持续性非卧床腹膜透析患者EPO低反应发生机制探讨[J].天津医科大学学报,2013,19(06):478.
SUN Peng,XIA Tian.Investigation on pathogenesis of erythropoietin hyporesponsiveness in patients with continuous ambulatory peritoneal dialysis[J].Journal of Tianjin Medical University,2013,19(02):478.
[3]王冰月,姜埃利,李春红,等.西沙比利对不同透析方式患者的消化道症状及胃肠激素影响研究[J].天津医科大学学报,2020,26(01):28.
WANG Bing-yue,JIANG Ai-li,LI Chun-hong,et al.Effects of Cisapride on symptoms of digestive and gastrointestinal hormones in patients with different dialysis modes[J].Journal of Tianjin Medical University,2020,26(02):28.